Disk Diffusion and Gradient Diffusion

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-27

Quick Answer

Disk diffusion measures a zone of growth inhibition around an antibiotic disk, while gradient diffusion measures a minimum inhibitory concentration (MIC) along a continuous concentration gradient.
Choose disk diffusion for routine susceptibility screening of fast-growing bacteria and gradient diffusion when an exact MIC value is needed for clinical dosing decisions.
Both methods require strict standardization of inoculum, media, incubation, and measurement, and neither method can replace broth dilution for every organism-drug combination.

Principles of Disk Diffusion Testing

Disk diffusion susceptibility testing, also known as the Kirby-Bauer method, relies on the diffusion of an antimicrobial agent from a paper disk into an agar medium. The antibiotic concentration decreases logarithmically as it moves away from the disk, creating a continuous concentration gradient across the agar surface. After incubation, a zone of inhibited bacterial growth appears around the disk where the antibiotic concentration exceeds the organism's susceptibility threshold.

The zone diameter is measured in millimeters and compared to established interpretive criteria to classify the organism as susceptible, intermediate, or resistant. The zone size reflects both the intrinsic activity of the drug and the diffusion characteristics of the molecule through the agar medium. Larger molecules diffuse more slowly, which can produce smaller zones even when the organism is susceptible to the drug.

The method works best for rapidly growing aerobic and facultative anaerobic bacteria. Organisms that require special growth conditions, such as anaerobes or fastidious species, often require alternative testing approaches. The Clinical and Laboratory Standards Institute publishes standardized protocols for disk diffusion testing that specify the exact media, inoculum density, incubation conditions, and measurement procedures that laboratories must follow.

Gradient Diffusion Principles

Gradient diffusion methods use a plastic strip impregnated with a continuous gradient of an antimicrobial agent. The strip is placed on an inoculated agar plate, and the antibiotic diffuses into the medium immediately after application. After incubation, an elliptical zone of inhibition forms around the strip. The point where the zone edge intersects the strip corresponds to the minimum inhibitory concentration, which is read directly from a printed scale on the strip.

The MIC value represents the lowest concentration of the antibiotic that inhibits visible bacterial growth under the standardized test conditions. This quantitative result provides more clinical information than the qualitative susceptible, intermediate, or resistant classification from disk diffusion. The MIC is particularly useful for determining appropriate dosing regimens, especially for drugs with narrow therapeutic windows or for infections at body sites where drug penetration is limited.

Gradient diffusion strips are available for a wide range of antibiotics and can be used for many clinically significant organisms. The method is more expensive per test than disk diffusion, but it provides a quantitative result that can guide therapeutic decisions. The American Type Culture Collection provides authenticated reference strains that laboratories use to validate the performance of gradient diffusion strips and other susceptibility testing materials.

At a Glance

Feature	Disk Diffusion	Gradient Diffusion
Result type	Qualitative zone diameter in millimeters	Quantitative MIC value
Primary use	Routine screening and susceptibility classification	Dosing decisions and resistance detection
Cost per test	Lower	Higher
Time to result	Typically 16 to 24 hours	Typically 16 to 24 hours
Organism range	Fast-growing aerobic bacteria	Broader range including some fastidious organisms
Interpretation	Requires zone diameter breakpoints	Requires MIC breakpoints
Quality control	Standard reference strains	Standard reference strains

Standardization Requirements

Inoculum Preparation

The accuracy of both disk diffusion and gradient diffusion depends on preparing a standardized inoculum. The direct colony suspension method is the preferred approach for most organisms. Several isolated colonies of the same morphology are selected from an overnight agar plate and suspended in sterile saline or broth. The turbidity of the suspension is adjusted to match a 0.5 McFarland standard, which corresponds to approximately 1 to 2 times 10 to the eighth colony forming units per milliliter for most bacteria.

The inoculum must be used within a defined time window after preparation to avoid changes in cell density. Overgrowth of the suspension can lead to falsely resistant results, while a light inoculum can produce falsely susceptible results. The American Society for Microbiology provides educational resources on the preparation of standardized inocula and the common errors that occur during this step.

The adjusted suspension is then applied to the surface of the agar plate. The standard method uses a sterile cotton swab dipped into the suspension, rotated against the tube wall to remove excess fluid, and then streaked across the entire agar surface in three directions to ensure an even lawn of growth. The plate should be allowed to dry for a few minutes before the disks or strips are applied.

Media Selection

Mueller-Hinton agar is the standard medium for disk diffusion and gradient diffusion testing of non-fastidious bacteria. The medium must be prepared according to the manufacturer's instructions and checked for the correct depth, which is typically 4 millimeters. The pH of the medium should be between 7.2 and 7.4 for most organisms. The agar surface must be free of bubbles, cracks, or unevenness that could affect the diffusion of the antibiotic.

The U.S. Food and Drug Administration publishes the Bacteriological Analytical Manual that describes the media preparation and quality control procedures used in official food microbiology laboratories. These procedures emphasize the importance of using fresh media and verifying the performance of each new batch of agar before it is used for susceptibility testing.

For fastidious organisms, the media may require supplementation. For example, the addition of blood or other nutrients may be necessary to support the growth of certain species. The choice of media must be documented in the laboratory records, and any deviation from the standard media must be validated before it is used for clinical testing.

Disk Placement and Strip Application

The antibiotic disks are placed on the inoculated agar surface using a dispenser or sterile forceps. The disks must be pressed gently to ensure full contact with the agar. The distance between disks must be sufficient to prevent overlapping zones of inhibition, which can occur when two antibiotics diffuse into the same area. The standard recommendation is to place no more than 12 disks on a standard 150 millimeter plate and no more than 5 disks on a 100 millimeter plate.

The gradient strips are placed on the agar surface with the scale facing upward. The strip must be in full contact with the agar, and any air bubbles under the strip must be removed by pressing gently. The strips should be placed in a radial pattern to avoid overlapping zones. The manufacturer instructions for the specific strip product must be followed for the correct placement and reading procedure.

Incubation Conditions

The plates are incubated in an inverted position to prevent condensation from dripping onto the agar surface. The standard incubation temperature is 35 degrees Celsius for most organisms, and the duration is typically 16 to 24 hours. The incubation atmosphere must be appropriate for the organism being tested. Some organisms require an increased carbon dioxide atmosphere, while others require anaerobic conditions.

The incubation time and temperature must be consistent with the standard method for the organism. Prolonged incubation can allow the antibiotic to degrade or the bacteria to resume growth, which can produce falsely resistant results. Short incubation can prevent the bacteria from reaching the growth phase needed for accurate zone measurement. The Clinical and Laboratory Standards Institute documents the specific incubation requirements for each organism and antibiotic combination.

Reading Zone Diameters

The zone diameter is measured at the point where there is a visible reduction in growth. The measurement is taken in millimeters using a ruler or a calibrated caliper. The reading should be done with the plate held at a distance from the eye to avoid parallax error. The zone edge is defined as the area where the growth is visibly reduced, not the area where the growth is completely absent.

For some antibiotics, the zone edge may be marked by the presence of tiny colonies or a faint haze of growth. The reading of these zones requires careful observation and may require the use of a magnifying lens. The presence of colonies within the zone can indicate the presence of a resistant subpopulation, which must be reported as a separate finding.

The zone diameter is recorded in the laboratory information system and compared to the interpretive criteria for the specific drug and organism. The interpretation is reported as susceptible, intermediate, or resistant. The intermediate category indicates that the organism may be treated with a higher dose of the drug or that the drug may be effective at a body site where the drug is concentrated.

Reading Gradient Strips

The MIC is read at the point where the edge of the zone of inhibition intersects the printed scale on the strip. The reading is made at the point where there is a sharp reduction in the bacterial growth. The MIC value is expressed in micrograms per milliliter. The reading must be performed with the plate held at the correct angle to avoid the parallax error.

For some drugs, the zone edge may be characterized by a haze of growth or the presence of microcolonies. The reading of these zones requires the use of the specific instructions provided by the strip manufacturer. The presence of a haze or microcolonies may indicate the presence of a resistant subpopulation, which must be reported as a separate finding.

The MIC value is then interpreted using the breakpoints for the drug and the organism. The breakpoints are established by the Clinical and Laboratory Standards Institute and are based on the pharmacokinetic and pharmacodynamic properties of the drug, the distribution of MIC values in the bacterial population, and the clinical outcomes of treatment.

Quality Control

Quality control is an essential component of the disk diffusion and gradient diffusion testing. The laboratory must test a set of standard reference strains on each day of testing to verify that the media, disks, strips, and the testing procedure are performing correctly. The reference strains are obtained from the American Type Culture Collection and include organisms with known susceptibility patterns.

The quality control results must fall within the acceptable ranges for the drug and the organism. If the quality control results are outside the acceptable range, the test results for the patient isolates are invalid and must be repeated. The quality control results must be documented in the laboratory records and reviewed on a regular basis to identify any trends that may indicate a problem with the testing system.

The Biosafety in Microbiological and Biomedical Laboratories provides the biosafety guidelines for the handling of the reference strains and the patient isolates. The laboratory must follow the appropriate biosafety level for the organisms being tested, and the waste must be decontaminated before disposal.

Common Failure Patterns

The most common failure in disk diffusion testing is the use of an incorrect inoculum density. A suspension that is too dense produces a smaller zone of inhibition, which can lead to a falsely resistant result. A suspension that is too dilute produces a larger zone, which can lead to a falsely susceptible result. The turbidity of the suspension must be verified against the standard before the testing is performed.

The use of the wrong media or the media with the wrong pH can also cause inaccurate results. The media must be prepared according to the manufacturer's instructions and the pH must be verified. The media must be used within the expiration date and must be stored under the correct conditions.

The placement of the disks or strips too close to the edge of the plate can cause the zone to be truncated, which can lead to an inaccurate measurement. The disks must be placed at least 15 millimeters from the edge of the plate. The strips must be placed in a radial pattern to avoid overlapping zones.

The reading of the zone diameter or the MIC must be performed by a trained laboratory professional. The reading must be done at the correct time after incubation. The reading of the zone edge is subjective and can vary between the readers. The laboratory must have a procedure for the verification of the readings by a second reader.

Interpretation and Reporting

The interpretation of the disk diffusion zone diameter and the gradient diffusion MIC must be performed using the current breakpoints for the drug and the organism. The breakpoints are updated periodically by the Clinical and Laboratory Standards Institute and the laboratory must use the most current version of the standards.

The report must include the organism identification, the drug tested, the zone diameter or the MIC value, and the interpretation. The report must also include the quality control results for the day of the testing. The report must be reviewed by the laboratory director or the designee before the results are released to the clinician.

The interpretation of the results must be done in the context of the clinical situation. The susceptibility result is a prediction of the likelihood of the clinical success of the drug. The result must be interpreted in the context of the patient's immune status, the site of the infection, and the pharmacokinetic properties of the drug.

Limitations of the Methods

The disk diffusion and gradient diffusion methods are limited to the organisms that grow well on the standard media. The methods are not suitable for the testing of the organisms that require special growth conditions or that grow slowly. The methods are also not suitable for the testing of the organisms that have a high rate of mutation to resistance.

The disk diffusion method provides a qualitative result and does not provide the exact MIC value. The gradient diffusion method provides the MIC value but is more expensive per test. The choice of the method depends on the clinical need and the laboratory resources.

The results of the susceptibility testing are based on the in vitro activity of the drug. The in vitro activity does not always predict the in vivo response. The clinical outcome depends on the host factors, the drug pharmacokinetics, and the site of the infection.

Biosafety and Waste Management

The handling of the bacterial cultures and the susceptibility testing plates requires the appropriate biosafety practices. The Biosafety in Microbiological and Biomedical Laboratories provides the risk assessment and the containment principles for the laboratory work with the bacteria. The laboratory must follow the biosafety level appropriate for the organism being tested.

The waste from the susceptibility testing must be decontaminated before disposal. The plates and the strips must be placed in the biohazard waste containers and autoclaved or incinerated. The laboratory must have a written procedure for the waste management and the decontamination.

The laboratory personnel must be trained in the biosafety practices and the use of the personal protective equipment. The training must be documented and the personnel must be assessed for the competency on a regular basis.

Antimicrobial Resistance Surveillance

The disk diffusion and gradient diffusion methods are used in the antimicrobial resistance surveillance programs. The data from the susceptibility testing are collected and analyzed to monitor the trends in the resistance of the bacterial populations. The surveillance data are used to inform the clinical guidelines and the public health policies.

The World Health Organization defines the antimicrobial resistance as the ability of the bacteria to resist the effects of the drugs that are designed to kill them. The surveillance of the resistance is a key component of the global action plan on the antimicrobial resistance. The data from the susceptibility testing are used to identify the emerging resistance patterns and to guide the stewardship of the antimicrobial use.

The laboratory must participate in the external quality assessment programs to verify the accuracy of the susceptibility testing. The external quality assessment provides the samples with the known results that are tested by the laboratory and the results are compared to the expected values. The participation in the external quality assessment is a requirement for the laboratory accreditation.

Practical Implementation Steps

The laboratory must establish a written procedure for the disk diffusion and gradient diffusion testing. The procedure must include the preparation of the media, the preparation of the inoculum, the placement of the disks or the strips, the incubation conditions, the reading of the results, and the interpretation of the results.

The laboratory must verify the performance of the method before the implementation. The verification includes the testing of the reference strains and the comparison of the results to the expected values. The verification must be documented and the results must be reviewed by the laboratory director.

The laboratory must train the personnel in the performance of the testing. The training must include the theoretical principles and the practical skills. The competency of the personnel must be assessed on a regular basis and the records of the competency must be maintained.

The laboratory must have a system for the recording and the reporting of the results. The results must be recorded in a manner that is traceable and the reports must be reviewed before the release. The laboratory must have a procedure for the handling of the results that are outside the quality control range.

Records and Measurements

The laboratory must maintain the records of the susceptibility testing for the period required by the regulatory and the accreditation requirements. The records must include the date of the testing, the identification of the organism, the antimicrobial agents tested, the zone diameters or the MIC values, the interpretation, and the quality control results.

The records must be stored in a secure manner and must be available for the review by the regulatory and the accreditation bodies. The records must be retained for the period specified by the laboratory's document control procedure.

The laboratory must maintain the records of the quality control testing. The quality control records must include the results of the reference strains and the corrective actions taken when the results are outside the acceptable range. The quality control records must be reviewed on a regular basis to identify the trends.

Professional Escalation Criteria

The laboratory professional must escalate the results that are unusual or that do not fit the expected pattern. The unusual results include the resistance to the drugs that are not commonly seen in the organism or the presence of the resistance to the multiple drugs. The escalation is done to the laboratory director or the clinical microbiologist.

The laboratory professional must escalate the results that are inconsistent with the clinical picture. The inconsistency may be due to the contamination of the culture or the error in the testing. The escalation is done to the clinical team to determine the need for the repeat testing.

The laboratory professional must escalate the results that are outside the quality control range. The escalation is done to the laboratory director for the investigation and the corrective action. The results of the patient are not released until the quality control issue is resolved.

A Practical Decision Framework for Selecting Disk Diffusion versus Gradient Diffusion

Choosing between disk diffusion and gradient diffusion is not a one-time laboratory decision. The correct choice depends on the organism, the drug, the clinical question, the workload, and the reporting requirements for each individual test request. A structured decision framework helps laboratory professionals make consistent, defensible choices that balance clinical utility, cost, and turnaround time.

Step 1: Confirm the Organism Is Eligible for the Method

The first decision point is whether the organism can be tested by either method at all. Disk diffusion is validated for fast-growing aerobic and facultative anaerobic bacteria that produce a confluent lawn of growth on Mueller-Hinton agar within 16 to 24 hours. Gradient diffusion is also validated for many of these organisms, but it has a broader range that includes some fastidious organisms when supplemented media are used.

Before selecting a method, confirm that the organism is listed in the current Clinical and Laboratory Standards Institute performance standards for the drug and method you intend to use. If the organism is not listed, neither disk diffusion nor gradient diffusion is appropriate, and you must use a reference method such as broth dilution. Organisms that grow poorly, require anaerobic conditions, or have unusual growth requirements should be referred to a laboratory with the appropriate testing capability.

Step 2: Assess the Clinical Need for a Quantitative Result

The next decision point is whether the clinician needs a qualitative classification or a quantitative MIC value. Disk diffusion provides a zone diameter in millimeters that is interpreted as susceptible, intermediate, or resistant. This is sufficient for routine clinical decisions when the drug has a wide therapeutic window and standard dosing is appropriate.

Gradient diffusion provides a numeric MIC value that is essential in several clinical situations. These include infections caused by organisms with borderline susceptibility, infections at body sites where drug penetration is limited, and patients who require dose optimization because of altered pharmacokinetics. The World Health Organization emphasizes that accurate MIC data are critical for antimicrobial stewardship programs that aim to optimize dosing and reduce the emergence of resistance.

Step 3: Evaluate the Drug and Organism Combination

Some drug and organism combinations are not appropriate for disk diffusion because the drug diffuses poorly in agar or because the zone edge is difficult to read. Gradient diffusion strips are manufactured for a wide range of drugs and organisms, but not every combination is available. The laboratory must verify that the specific strip product is validated for the organism and drug being tested.

The American Type Culture Collection provides authenticated reference strains that are used to verify the performance of both disk diffusion and gradient diffusion for each drug and organism combination. If a reference strain is not available for a particular combination, the laboratory should not report results for that combination until the method has been validated.

Step 4: Consider the Laboratory Workflow and Resources

The laboratory must consider the volume of testing, the cost per test, and the available personnel time. Disk diffusion is the lower-cost method and is appropriate for high-volume routine screening. Gradient diffusion is more expensive per test and is best reserved for situations where the quantitative result will change the clinical management.

The laboratory must also consider the time required for reading and interpretation. Disk diffusion zones are measured in millimeters and interpreted using breakpoint tables. Gradient diffusion MICs are read directly from the strip scale and interpreted using MIC breakpoints. Both methods require trained personnel, but gradient diffusion reading can be more subjective for drugs with a trailing endpoint or a haze of growth.

Step 5: Document the Decision and the Rationale

Every susceptibility test request should be reviewed against this decision framework, and the choice of method should be documented in the laboratory record. The documentation should include the organism, the drug, the method used, and the reason for the method selection. This documentation supports the interpretation of the result and provides a record for audit and review.

The American Society for Microbiology provides educational resources on the selection and validation of susceptibility testing methods. The laboratory should use these resources to train personnel and to establish a written policy for method selection.

A Record System for Susceptibility Testing Decisions

A structured record system is essential for tracking the method selection, the testing conditions, and the results for each isolate. The record system should be designed to support the quality control program and to provide the data needed for the antimicrobial resistance surveillance.

The Testing Request Record

The testing request record should capture the following information for each isolate:

The date and time of the request
The patient identifier and the specimen source
The organism identification and the method used for the identification
The drugs requested and the method selected for each drug
The reason for the method selection, such as the clinical need for a quantitative result

This record is the starting point for the traceability of the testing process. It should be completed before the testing begins and should be reviewed by the laboratory supervisor.

The Testing Log

The testing log records the technical details of the testing. It should include:

The media lot number and the expiration date
The disk or strip lot number and the expiration date
The inoculum preparation method and the McFarland standard verification
The incubation conditions, including the temperature, the atmosphere, and the duration
The zone diameter or the MIC value for each drug
The interpretation for each drug
The quality control results for the day of the testing

The testing log must be completed at the time of the testing and must be signed by the person who performed the test. The log must be reviewed by the supervisor before the results are released.

The Quality Control Record

The quality control record must document the results of the reference strains tested on each day of testing. The record should include:

The reference strain identifier and the source
The drug tested and the expected zone diameter or MIC range
The observed zone diameter or MIC value
The pass or fail status for each drug
The corrective action taken if the result is outside the acceptable range

The quality control record must be reviewed on a regular basis to identify trends. A trend toward the edge of the acceptable range may indicate a problem with the media, the disks, the strips, or the testing procedure. The Biosafety in Microbiological and Biomedical Laboratories provides the biosafety context for the handling of the reference strains and the patient isolates.

The Reporting Record

The reporting record must document the final result that is released to the clinician. The record should include:

The organism identification
The drug tested
The zone diameter or the MIC value
The interpretation
The date and time of the report
The name of the person who released the report

The reporting record must be traceable to the testing log and the quality control record. The laboratory must have a procedure for the correction of the reported results if an error is identified after the release.

Troubleshooting Method Selection and Results

Even with a clear decision framework and a complete record system, problems will occur. The following troubleshooting approach addresses the most common issues in the method selection and the interpretation.

Problem: The Zone Diameter Does Not Match the Expected Pattern

When a zone diameter is larger or smaller than expected for the organism and the drug, the first step is to verify the organism identification. A mixed culture or a misidentified organism can produce a zone that does not match the expected pattern. The identification should be repeated from the original culture.

If the identification is correct, the next step is to check the quality control results for the day of the testing. If the quality control results are within the acceptable range, the problem is likely with the patient isolate. The presence of a resistant subpopulation or a mixed culture can produce an unusual zone. The test should be repeated from a fresh subculture.

If the quality control results are outside the acceptable range, the patient results are invalid. The laboratory must investigate the cause of the quality control failure before repeating the patient test. The investigation should include the media, the disks, the strips, the inoculum, and the incubation conditions.

Step: The MIC Is Higher Than Expected

When the gradient diffusion MIC is higher than expected for the organism and the drug, the laboratory must consider the possibility of a technical error. The inoculum may have been too dense, the strip may not have been in full contact with the agar, or the incubation may have been too long. The test should be repeated with a fresh inoculum and a new strip.

If the repeat test confirms the high MIC, the result should be reported and the clinician should be notified. The high MIC may indicate the presence of a resistant subpopulation or the emergence of resistance during the therapy. The World Health Organization provides the context for the clinical significance of the elevated MIC values and the need for the antimicrobial stewardship.

Step: The Zone Edge Is Difficult to Read

Some drugs produce a zone edge that is marked by a haze of growth or a trailing endpoint. The reading of these zones requires the use of the specific instructions provided by the manufacturer. The laboratory should have a written procedure for the reading of the difficult zones and the personnel should be trained in the reading of these zones.

If the zone edge cannot be read reliably, the laboratory should consider the use of the gradient diffusion method to obtain a quantitative MIC. The gradient diffusion method may provide a clearer endpoint for the drugs with the trailing endpoints. The laboratory must verify that the gradient diffusion method is validated for the drug and the organism.

Step: The Quality Control Is Out of Range

The quality control results are the first line of defense against the inaccurate testing. When the quality control results are outside the acceptable range, the laboratory must take the following steps:

Document the out-of-range result in the quality control record.
Notify the laboratory supervisor or the director.
Investigate the cause of the failure.
Take the corrective action.
Repeat the quality control testing.
Document the corrective action and the repeat results.

The investigation should include the review of the media preparation, the disk or the strip storage, the inoculum preparation, and the incubation conditions. The U.S. Food and Drug Administration provides the quality control procedures for the media and the reagents used in the food microbiology laboratories, and the same principles apply to the clinical laboratory.

Common Failure Patterns in Method Selection

The following failure patterns are the most common in the selection and the use of the disk diffusion and the gradient diffusion methods.

Failure Pattern 1: Using Disk Diffusion When an MIC Is Required

The most common failure is the use of the disk diffusion method when the clinical situation requires a quantitative MIC. This occurs when the laboratory does not have a policy for the method selection or when the personnel are not trained to recognize the clinical need for the MIC. The result is a report that provides a susceptible, intermediate, or resistant classification but does not provide the MIC value needed for the dosing decision.

The corrective action is to establish a policy for the method selection and to train the personnel to apply the policy. The policy should specify the clinical situations that require the gradient diffusion method, such as the infections with the organisms that have the inducible resistance or the patients who require the dose optimization.

Failure Pattern 2: The Use of the Gradient Diffusion for the Routine Screening

The use of the gradient diffusion for the routine screening of the all isolates is the opposite failure. This approach increases the cost of the testing without providing the additional clinical benefit. The gradient diffusion should be reserved for the isolates and the clinical situations where the MIC value will change the clinical decision.

The failure is often caused by the laboratory that has the gradient diffusion strips available and uses them for the all testing to simplify the workflow. The corrective action is to establish a policy that defines the criteria for the use of the gradient diffusion and to monitor the use of the strips to ensure that the policy is followed.

Failure Pattern 3: The Inconsistent Application of the Decision Framework

The decision framework must be applied consistently to every isolate. The failure occurs when the personnel apply the framework differently for the different isolates or when the framework is not documented. The result is the inconsistent testing and the reporting that can lead to the clinical errors.

The corrective action is to document the decision framework in the laboratory procedure and to train the personnel in the application of the framework. The laboratory should also conduct the periodic audits of the testing records to verify that the framework is applied consistently.

Failure Pattern 4: The Failure to Document the Method Selection

The failure to document the method selection is a common problem in the laboratory. The testing log may show the zone diameter or the MIC value but not the reason for the method selection. This makes it difficult to review the testing and to identify the errors.

The corrective action is to require the documentation of the method selection in the testing log. The documentation should include the reason for the method selection, such as the clinical need for the MIC or the availability of the gradient strip for the drug and the organism.

The Role of the Method Selection in the Antimicrobial Stewardship

The selection of the disk diffusion or the gradient diffusion method has a direct impact on the antimicrobial stewardship. The World Health Organization defines the antimicrobial stewardship as the coordinated interventions that are designed to improve and measure the appropriate use of the antimicrobials. The susceptibility testing is a key component of the stewardship because it provides the data that the clinicians use to select the appropriate drug and the dose.

The disk diffusion method provides the qualitative classification that is sufficient for the selection of the drug in the many cases. The gradient diffusion method provides the quantitative MIC that is used to optimize the dose, especially for the drugs with the narrow therapeutic window or the infections at the body sites with the limited drug penetration.

The laboratory must work with the clinical team to ensure that the susceptibility testing is used to the full extent of the clinical need. The laboratory should provide the education to the clinicians on the interpretation of the zone diameters and the MIC values and the situations where the MIC is required. The laboratory should also participate in the antimicrobial stewardship program and provide the data for the monitoring of the resistance trends.

The American Society for Microbiology provides the professional education on the antimicrobial stewardship and the role of the laboratory in the stewardship. The laboratory should use these resources to train the personnel and to develop the policies for the method selection and the reporting.

The Role of the External Quality Assessment in the Method Selection

The external quality assessment is a critical component of the quality assurance for the susceptibility testing. The external quality assessment provides the samples with the known results that are tested by the laboratory and the results are compared to the expected values. The participation in the external quality assessment is a requirement for the laboratory accreditation.

The external quality assessment can also be used to evaluate the method selection. The samples may include the isolates that require the gradient diffusion for the accurate MIC determination. The laboratory's performance on these samples can be used to identify the problems with the method selection and the interpretation.

The laboratory should review the external quality assessment results on a regular basis and take the corrective action when the results are not satisfactory. The corrective action may include the retraining of the personnel, the revision of the procedures, or the change in the method selection.

The Role of the Laboratory Director in the Method Selection

The laboratory director is responsible for the establishment and the oversight of the method selection policy. The director must ensure that the policy is based on the current Clinical and Laboratory Standards Institute standards and that the personnel are trained in the application of the policy.

The laboratory director must also review the quality control records and the external quality assessment results on a regular basis. The director must investigate the failures and take the corrective action. The director must also ensure that the laboratory has the resources to perform the testing, including the appropriate media, the disks, the strips, and the personnel.

The laboratory director must also ensure that the laboratory is in compliance with the biosafety requirements. The Biosafety in Microbiological and Biomedical Laboratories provides the guidelines for the risk assessment and the containment of the biological agents. The laboratory must follow the appropriate biosafety level for the organisms being tested and the waste must be decontaminated before the disposal.

The Role of the Clinical Microbiologist in the Method Selection

The clinical microbiologist is responsible for the interpretation of the susceptibility testing results and the communication with the clinical team. The clinical microbiologist must be familiar with the method selection policy and the limitations of the disk diffusion and the gradient diffusion methods.

The clinical microbiologist must also be able to identify the situations where the susceptibility testing results are not consistent with the clinical picture. The inconsistency may be due to the contamination of the culture, the error in the testing, or the presence of the resistant subpopulation. The clinical microbiologist must escalate the results to the clinical team and recommend the appropriate action.

The clinical microbiologist must also be able to interpret the MIC values in the context of the clinical situation. The MIC value is a prediction of the likelihood of the clinical success of the drug. The result must be interpreted in the context of the patient's immune status, the site of the infection, and the pharmacokinetic properties of the drug.

The Role of the Laboratory Professional in the Method Selection

The laboratory professional who performs the testing is responsible for the application of the method selection policy. The laboratory professional must be trained in the decision framework and the record system. The laboratory professional must also be able to identify the problems in the testing and to escalate the problems to the supervisor.

The laboratory professional must also be responsible for the accurate reading of the zone diameters and the MIC values. The reading of the zone edge is subjective and can vary between the readers. The laboratory must have a procedure for the verification of the readings by a second reader.

The laboratory professional must also be responsible for the accurate documentation of the testing. The documentation must be complete and traceable. The documentation must be reviewed by the supervisor before the results are released.

The Role of the External Quality Assessment in the Method Selection

The external quality assessment can also be used to evaluate the method selection. The samples may include the isolates that require the gradient diffusion for the accurate MIC. The laboratory should assess the performance on these samples to identify the problems with the method selection and the interpretation.

The laboratory should review the external quality assessment results on a regular basis and take the corrective action when the results are not satisfactory. The corrective action should include the retraining of the personnel, the revision of the procedures, or the change in the method selection.

The Use of the Decision Framework in the Antimicrobial Resistance Surveillance

The decision framework for the method selection also applies to the antimicrobial resistance surveillance. The surveillance programs collect the susceptibility data from the clinical laboratories to monitor the trends in the resistance. The data from the disk diffusion and the gradient diffusion methods are used in the surveillance.

The surveillance data must be comparable across the laboratories. The laboratories must use the same methods and the same breakpoints to ensure the comparability of the data. The World Health Organization provides the guidance on the surveillance of the antimicrobial resistance and the use of the susceptibility testing data.

The decision framework should be applied consistently in the surveillance. The laboratories should use the gradient diffusion for the isolates that require the MIC for the surveillance, such as the isolates with the emerging resistance or the isolates that are part of the specific surveillance programs. The use of the gradient diffusion in the surveillance provides the more detailed data on the MIC distribution and the resistance mechanisms.

The Practical Implementation of the Decision Framework

The implementation of the decision framework requires the following steps:

Establish the written policy for the method selection. The policy should include the criteria for the use of the disk diffusion and the gradient diffusion and the documentation requirements.
Train the personnel in the application of the policy. The training should include the theoretical principles and the practical skills.
Verify the performance of the method before the implementation. The verification includes the testing of the reference strains and the comparison of the results to the expected values.
Implement the record system for the method selection and the testing results.
Monitor the application of the policy and the quality control results on a regular basis.
Review the external quality assessment results and take the corrective action when the results are not satisfactory.

The laboratory should also conduct the periodic audits of the testing records to verify that the policy is applied consistently. The audits should include the review of the testing logs, the quality control records, and the reporting records. The audit should be documented and the findings should be reviewed by the laboratory director.

The Limitations of the Decision Framework

The decision framework is a guide, not a substitute for the professional judgment. The laboratory professional must use the clinical judgment in the application of the framework. The framework does not cover every clinical situation and the laboratory professional must be able to identify the situations where the framework does not apply.

The decision framework is also limited by the availability of the gradient diffusion strips. The strips are not available for every drug and organism combination. The laboratory must verify the availability of the strips before the testing and must have a backup plan for the drugs that are not available.

The decision framework is also limited by the cost of the gradient diffusion. The gradient diffusion is more expensive than the disk diffusion. The laboratory must balance the cost of the testing with the clinical benefit of the MIC value. The laboratory must also consider the cost of the quality control and the training.

The decision framework is also limited by the time required for the testing. The gradient diffusion and the disk diffusion both require the incubation of 16 to 24 hours. The laboratory must consider the turnaround time for the clinical decision and the need for the rapid testing. The laboratory must also consider the need for the repeat testing when the results are not clear.

The Future of the Method Selection

The method selection will continue to evolve as the new drugs and the new testing methods are developed. The laboratory must stay current with the new standards and the new methods. The Clinical and Laboratory Standards Institute publishes the updated standards on a regular basis and the laboratory must use the current version of the standards.

The laboratory must also stay current with the new gradient diffusion strips and the new disk diffusion products. The laboratory must verify the performance of the new products before the implementation. The American Type Culture Collection provides the reference strains for the verification of the new products.

The laboratory must also stay current with the new clinical guidelines and the new antimicrobial stewardship programs. The World Health Organization provides the global guidance on the antimicrobial resistance and the stewardship. The laboratory must use the guidance to inform the method selection and the reporting.

The laboratory must also stay current with the new biosafety requirements. The Biosafety in Microbiological and Biomedical Laboratories provides the guidance on the biosafety and the containment. The laboratory must follow the guidance to ensure the safety of the personnel and the environment.

Frequently Asked Questions

What is the difference between the disk diffusion and the gradient diffusion?

The disk diffusion method measures the zone of inhibition in millimeters and provides a qualitative classification of the organism as susceptible, intermediate, or resistant. The gradient diffusion method measures the minimum inhibitory concentration directly from the scale on the strip and provides a quantitative value that can be used for the dosing decisions.

Why is the Mueller-Hinton agar used for the susceptibility testing?

Mueller-Hinton agar is the standard medium for the disk diffusion and gradient diffusion testing because it provides the consistent growth of the bacteria and the reproducible diffusion of the antibiotics. The medium is low in the inhibitors that can interfere with the antibiotic activity and the pH is controlled to the standard range.

How is the inoculum standardized for the susceptibility testing?

The inoculum is standardized by the preparation of a suspension of the bacteria in the saline that is adjusted to the turbidity of the 0.5 McFarland standard. The suspension is used within a defined time and the density is verified before the testing.

What is the difference between the susceptible, intermediate, and resistant categories?

The susceptible category indicates that the organism is likely to respond to the standard dose of the drug. The intermediate category indicates that the organism may respond to a higher dose or that the drug may be effective at a body site where the drug is concentrated. The resistant category indicates that the organism is not likely to respond to the drug.

What is the minimum inhibitory concentration?

The minimum inhibitory concentration is the lowest concentration of the antibiotic that inhibits the visible growth of the bacteria under the standardized test conditions. The MIC is expressed in the micrograms per milliliter and is used to guide the dosing of the antibiotic.

How often are the breakpoints updated?

The breakpoints are updated by the Clinical and Laboratory Standards Institute on a regular basis. The laboratory must use the current version of the standards and must verify the breakpoints for the drugs and the organisms that are tested.

What is the role of the quality control in the susceptibility testing?

The quality control is used to verify that the testing system is performing correctly. The reference strains with the known susceptibility values are tested on each day of the testing and the results are compared to the acceptable ranges. The patient results are valid only when the quality control results are within the acceptable range.

What are the limitations of the disk diffusion method?

The disk diffusion method does not provide the exact MIC value and is not suitable for the organisms that require the special growth conditions. The method is also limited to the drugs that diffuse well in the agar and the results are based on the in vitro activity of the drug.

Using the Evidence

Source	Best use in this topic	Important limitation
Biosafety in Microbiological and Biomedical Laboratories	official guidance	Check the linked page for current local requirements
Microbiology Resources	official guidance	Check the linked page for current local requirements
Antimicrobial Resistance	official guidance	Check the linked page for current local requirements

Related Bacteriology Guides

References and Further Reading

Biosafety in Microbiological and Biomedical Laboratories. CDC and NIH.
Microbiology Resources. American Society for Microbiology.
Antimicrobial Resistance. World Health Organization.
Bacteriological Analytical Manual. U.S. Food and Drug Administration.
Antimicrobial Susceptibility Testing. Clinical and Laboratory Standards Institute.
Culture Collections. American Type Culture Collection.
NCBI Pathogen Detection. National Center for Biotechnology Information.
Performance of gradient diffusion strip and disk diffusion versus broth microdilution for lefamulin susceptibility testing of 422 Staphylococcus aureus isolates.. Journal of clinical microbiology, 2026.
In Vitro Activity of Cefiderocol, Eravacycline, and Imipenem-Relebactam Against Multidrug-Resistant &lt,i&gt,Acinetobacter baumannii&lt,/i&gt, Clinical Isolates.. 2026.
J-AST: a web-based analysis platform for antimicrobial susceptibility testing. 2026.
Impact of Outdated Clinical and Laboratory Standards Institute (CLSI) Breakpoint Implementation on Antimicrobial Susceptibility Interpretation: A Retrospective Analytical Study.. 2026.

This article is educational and does not replace validated laboratory procedures, clinical diagnosis, institutional biosafety review, or public-health guidance.